MedTrace Logo

Online Adaptive Radiotherapy for Cervical Cancer

NCT06562166 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2026-01-08

No results posted yet for this study

Summary

This study aims to evaluate the clinical efficacy and safety of online adaptive radiotherapy for cervical cancer patients received radical radiotherapy. By comparing with image-guided radiotherapy, the study explores the potential advantages of online adaptive radiotherapy in reducing treatment toxicity and improving local control.

Conditions

Interventions

RADIATION

online adaptive radiotherapy

Patients in ART group received daily online adaptive radiotherapy with a prescription dose of 50.4Gy/28f.

Sponsors & Collaborators

  • The First Affiliated Hospital of Jiangsu University

    collaborator UNKNOWN

  • Zhongnan Hospital

    collaborator OTHER

  • Jingzhou First People's Hospital

    collaborator UNKNOWN

  • The First Affiliated Hospital of Nanhua University

    collaborator UNKNOWN

  • Tongji Hospital

    collaborator OTHER

  • Peking Union Medical College Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-05
Primary Completion
2027-08-01
Completion
2028-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06562166 on ClinicalTrials.gov